POM-V Prescription Required

Folltropin 700 IU Powder and Solvent for Solution for Injection

Active ingredient: Follicle Stimulating Hormone (porcine)

Form

Injection

Species

Cattle

Manufacturer

Vetoquinol SA

VMD MA No.

06462/3026

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Follicle Stimulating Hormone...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Folltropin 700 IU Powder and Solvent for Solution for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Dissolve each vial of freeze-dried product with the enclosed solvent. Reconstitution and
subsequent withdrawal of product should be performed using strict aseptic technique.
Regimen:
Start injections on day 8 to 10 following observed or induced oestrus. Administer 2.5 ml (87
.5 I.U.) of the product intramuscularly, twice daily, for 4 days. In conjunction with the 6th
dose of the product, administer prostaglandin F2α or a prostaglandin F2α analogue, at their
manufacturer's recommended dose, to cause luteolysis.
Inseminate animals at 12 and 24 hours after the onset of oestrus or 60 and 72 hours after
prostaglandin treatment. Additional inseminations may be conducted at 12 hour intervals if
indicated.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not use in males and reproductively immature female cattle.
Do not use in pregnant cattle.

Target species: cattle (reproductively mature females).
Very rare
(<1 animal / 10,000 animals
treated, including isolated reports):
Ovarian cyst*, lack of heat**
* Following administration for three superovulation cycles, but did not prevent pregnancy.
** Following superovulation a delayed return to heat is possible.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary
medicinal product. Reports should be sent, preferably via a veterinarian, to either the
marketing authorisation holder or its local representative or the national competent authority
via the national reporting system. See the package leaflet for respective contact details.

None.

Special precautions for safe use in the target species:
The product should only be used in clinically healthy cows and mature heifers, which are
cycling normally. There is a wide range in response to superovulation between animals.
There may be a small proportion of non-responders in any group treated.
Collection of embryo is normally started on day 7 following observed oestrus or first
breeding. Prior to breeding and the collection of fertilized embryo from these animals,
oestrus will have to be induced with prostaglandin F2α or a prostaglandin F2α analogue.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Care should be taken when handling the product to avoid self-injection. Accidental self-
injection of FSH may cause biological effects in women and to the unborn child. In case of
accidental self- injection in women who are pregnant, or whose pregnancy status is
unknown, seek medical advice immediately and show the package leaflet or the label to the
physician.
Special precautions for the protection of the environment:
Not applicable.

None known.

Freeze dried powder and solvent vials: Do not store above 25ºC.
Reconstituted solution: Store in a refrigerator (2 - 8ºC).
Keep the vials in the outer carton in order to protect from light.

Meat and offal: Zero days.
Milk: Zero hours.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.